φ(ai) PHI AI
DocumentationDocs
Repository
In context
Charline Paucek MRN-101495 · born 1975-08-28 ✦ AI Ask ✦ AI Ambient note Chart
Chart · view recorded under the Health care operations purpose
Charline Paucek MRN-101495 Born Aug 28, 1975 (51) Sex female Payer UnitedHealthcare Fall River, MA
AI summary drafted by claude-sonnet-5 from this record · verify against the chart

Charline Paucek is a 49-year-old woman with a long-standing history of type 2 diabetes mellitus, now complicated by diabetic neuropathy, alongside metabolic syndrome, obesity, hyperlipidemia, and hypertriglyceridemia. Her glucose control appears suboptimal with persistently elevated readings and A1c trending upward. She is managed on metformin and simvastatin and has had recent routine follow-up, eye exam, and dental care.

Drives care
  • Type 2 diabetes mellitus with neuropathy
  • Poor glycemic control (elevated glucose, rising A1c)
  • Obesity (BMI 30+)
  • Hyperlipidemia/hypertriglyceridemia
Watch
  • A1c 7.54% (2023) trending up from 7.39% (2022) - needs recheck
  • Recent glucose readings 127-130 mg/dL still above target
  • No recent lipid panel or updated A1c on file since 2023
Withheld from this view and from assistant retrieval: 1 × Reproductive health · 2 × Mental health. Sensitive-category records exist and are counted, never silently absent — reaching them takes the dedicated role and path, and every access is audited as a disclosure. Your psychotherapy role can open the notes below.

Active problems

ConditionStatusOnset
Hyperglycemia (disorder) active Jun 5, 2024
Body mass index 30+ - obesity (finding) active May 31, 2023
Hyperlipidemia (disorder) active May 17, 2017
Neuropathy due to type 2 diabetes mellitus (disorder) active May 13, 2015
Hypertriglyceridemia (disorder) active Jul 18, 2012
Metabolic syndrome X (disorder) active Jul 18, 2012
Diabetes mellitus type 2 (disorder) active Jul 15, 2009
Prediabetes (finding) active Nov 13, 2002

Active medications

MedicationDosageSince
Simvastatin 10 MG Oral Tablet Jun 12, 2025
24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet Jun 11, 2025

Allergies

SubstanceReactionVerification
No known allergies recorded.

Recent results

TestValueWhen
HDL cholesterol 55.036 mg/dL Jun 12, 2025
LDL cholesterol 95.437 mg/dL Jun 12, 2025
Triglycerides 184.96 mg/dL Jun 12, 2025
Total cholesterol 178.19 mg/dL Jun 12, 2025
eGFR 83.696 mL/min Jun 12, 2025
Potassium 4.91 mmol/L Jun 12, 2025
Sodium 142.43 mmol/L Jun 12, 2025
Glucose abnormal 129.62 mg/dL Jun 12, 2025
eGFR 64.88 mL/min/{1.73_m2} Jun 11, 2025
HDL cholesterol 37.64 mg/dL Jun 11, 2025
LDL cholesterol 115.85 mg/dL Jun 11, 2025
Triglycerides 477.32 mg/dL Jun 11, 2025
Total cholesterol 248.96 mg/dL Jun 11, 2025
Potassium 4 mmol/L Jun 11, 2025
Sodium 136.58 mmol/L Jun 11, 2025
Glucose abnormal 127.56 mg/dL Jun 11, 2025
Respiratory rate 14 /min Jun 11, 2025
Heart rate 99 /min Jun 11, 2025
BMI 27.92 kg/m2 Jun 11, 2025
Body weight 70.4 kg Jun 11, 2025
Pain severity 1 {score} Jun 11, 2025
Body height 158.8 cm Jun 11, 2025
Hemoglobin A1c 5.48 % Jun 11, 2025
HDL cholesterol 56.691 mg/dL Jun 12, 2024
LDL cholesterol 110.75 mg/dL Jun 12, 2024
Triglycerides 129.96 mg/dL Jun 12, 2024
Total cholesterol 184.97 mg/dL Jun 12, 2024
eGFR 70.631 mL/min Jun 12, 2024
Potassium 4.28 mmol/L Jun 12, 2024
Sodium 142.94 mmol/L Jun 12, 2024

Notes & documents

DocumentAuthorDate
No unrestricted documents.

Claims

ClaimPayerDateStatus BilledPaid
CLM-2026185000UnitedHealthcare Feb 4, 2026 paid $4,052.91 $3,128.26 Lines
CLM-2026185002UnitedHealthcare Dec 23, 2025 paid $2,730.98 $2,070.72 Lines
CLM-2026185001UnitedHealthcare Dec 23, 2025 paid $129.94 $0.00 Lines
CLM-2026185003UnitedHealthcare Jun 25, 2025 pending $301.68 $0.00 Lines
CLM-2026185005UnitedHealthcare Jun 12, 2025 paid $234.71 $119.33 Lines
CLM-2026185004UnitedHealthcare Jun 12, 2025 paid $35.93 $0.00 Lines
CLM-2026185007UnitedHealthcare Jun 11, 2025 paid $989.36 $2,509.13 Lines
CLM-2026185006UnitedHealthcare Jun 11, 2025 paid $46.15 $0.00 Lines

Documentation drafts — this patient

No drafts for this patient yet. Ambient notes and AI-drafted documents land here, on the chart they belong to — and in the cross-patient Signature queue.